Rezolute (RZLT) Non-Current Assets (2012 - 2026)

Rezolute's (RZLT) quarterly Non-Current Assets came in at $3.4 million in Q1 2026, down 43.2% year-on-year from $6.0 million in Q1 2025, and down 3.21% quarter-over-quarter from $3.5 million in Q4 2025.

Rezolute (RZLT) Non-Current Assets (2012 - 2026) Analysis & Trends

Rezolute has disclosed Non-Current Assets across 15 years of filings, most recently posting $3.4 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $3.4 million, down 43.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.2 million (down 58.42% YoY), and the FY2025 annual result was $4.3 million, up 6.39% from the prior year.
  • Non-Current Assets came in at $3.4 million for Q1 2026 at Rezolute, down from $3.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $28.7 million in Q1 2023 to a low of $316000.0 in Q2 2022.
  • The 5-year median for Non-Current Assets is $5.2 million (2022), against an average of $7.6 million.
  • Across the five-year window, Non-Current Assets jumped 5852.85% in 2023 and sank 80.73% in 2024, its largest moves.
  • Rezolute's Non-Current Assets stood at $2.6 million in 2022, then surged by 133.09% to $6.1 million in 2023, then soared by 119.51% to $13.3 million in 2024, then plunged by 73.54% to $3.5 million in 2025, then retreated by 3.21% to $3.4 million in 2026.
  • The last three Non-Current Assets figures came in at $3.4 million (Q1 2026), $3.5 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Rezolute 520.13 Mn 520.13 Mn - 3.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.41 Mn
Dec 31, 2025 3.52 Mn
Sep 30, 2025 3.96 Mn
Jun 30, 2025 4.35 Mn
Mar 31, 2025 6.00 Mn
Dec 31, 2024 13.31 Mn
Sep 30, 2024 13.24 Mn
Jun 30, 2024 4.08 Mn
Mar 31, 2024 5.53 Mn
Dec 31, 2023 6.07 Mn
Sep 30, 2023 10.35 Mn
Jun 30, 2023 18.81 Mn
Mar 31, 2023 28.68 Mn
Dec 31, 2022 2.60 Mn
Sep 30, 2022 361,000.00
Jun 30, 2022 316,000.00
Mar 31, 2022 5.24 Mn
Dec 31, 2021 5.31 Mn
Sep 30, 2021 415,000.00
Jun 30, 2021 616,000.00